Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Nanofat Versus Platelet Poor Plasma Gel for Infraorbital Rejuvenation

ID
Name
MS.21.09.1640
Description
this study was conducted for evaluation of the clinical efficacy, safety, and potential side effects of platelet poor plasma gel versus nonfat injection in infraorbital rejuvenation
Trial arms
Trial start
2021-06-01
Estimated PCD
2023-06-01
Trial end
2023-06-01
Status
Completed
Phase
Early phase I
Treatment
platelet poor plasma gel
injection of platelet poor plasma gel in the dark circles around the eye to rejuvenate and improve pigmentation
Arms:
platelet poor plasma gel group
nanofat
injection of nanofat in the dark circles around the eye to rejuvenate and improve pigmentation
Arms:
nanofat group
Size
60
Primary endpoint
the degree of changes in the skin texture and homogeneity
3 months
Eligibility criteria
Inclusion Criteria: * all patients with infraorbital dark circles Exclusion Criteria: * pregnancy * breast feeding * infectious disorders
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE1'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 60, 'type': 'ACTUAL'}}
Updated at
2024-03-19

1 organization

2 products

1 indication

Organization
Mansoura University
Product
Platelet poor plasma gel
Indication
Tear Trough Eyelid Deformity
Product
nanofat